[CLDX] YoY Quarter Result on 30-Jun-2020 [#Q2]

Stock
[CLDX] Celldex Therapeutics, Inc.
Announcement Date
06-Aug-2020
Financial Year
2020
Quarter
30-Jun-2020 [#Q2]
Profit Trend
QoQ- 12.63%
YoY- 6.35%
Quarter Report
CLDX's Result
CLDX's Financial Summary
View:
Show?
Quarter Result
30/06/23 30/06/22 30/06/21 30/06/20 30/06/19 30/06/18 30/06/17 CAGR
Revenue 268 163 3,480 236 715 2,763 3,829 -35.79%
PBT -30,502 -36,004 -13,373 -11,259 -11,779 -16,407 -28,566 1.09%
Tax -3,459 16,564 382 -228 -2,990 -15,798 1,276 -
NP -30,502 -52,568 -13,373 -11,031 -11,779 -16,407 -28,566 1.09%
Tax Rate - - - - - - - -
Total Cost 30,770 52,731 16,853 11,267 12,494 19,170 32,395 -0.85%
Ratio Analysis
30/06/23 30/06/22 30/06/21 30/06/20 30/06/19 30/06/18 30/06/17 CAGR
NP Margin -11,381.34 -32,250.31 -384.28 -4,674.15 -1,647.41 -593.81 -746.04 57.45%
Per Share
30/06/23 30/06/22 30/06/21 30/06/20 30/06/19 30/06/18 30/06/17 CAGR
EPS -0.65 -1.12 -0.34 -0.50 -0.84 -1.67 -3.42 -24.16%
EPS Diluted -0.65 -1.12 -0.34 -0.50 -0.84 -1.67 -3.42 -24.16%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.